Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors

Author： Doi Toshihiko   Ohtsu Atsushi   Fuse Nozomu   Yoshino Takayuki   Tahara Makoto   Shibayama Kazuhiro   Takubo Takatoshi   Weinreich David  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.71, Iss.1, 2013-01, pp. : 227-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors

By Fujisaka Yasuhito   Yamada Yasuhide   Yamamoto Noboru   Shimizu Toshio   Fujiwara Yutaka   Yamada Kazuhiko   Tamura Tomohide   Watanabe Hiroyuki   Sun Yu-Nien   Bass Michael   Seki Mitsuo  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 935-943

Springer Publishing Company

Access to resources Recommend Favorite

Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer

By Eatock M. M.   Tebbutt N. C.   Bampton C. L.   Strickland A. H.   Valladares-Ayerbes M.   Swieboda-Sadlej A.   Van Cutsem E.   Nanayakkara N.   Sun Y.-N.   Zhong Z. D.   Bass M. B.   Adewoye A. H.   Bodoky G.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 710-718

Oxford University Press

Access to resources Recommend Favorite

Phase 1 and dose-finding study of patritumab (U3-1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors

By Wakui Hiroshi   Yamamoto Noboru   Nakamichi Shinji   Tamura Yousuke   Nokihara Hiroshi   Yamada Yasuhide   Tamura Tomohide  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 511-516

Springer Publishing Company

Access to resources Recommend Favorite

A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors

By Okamoto Wataru   Yoshino Takayuki   Takahashi Toshiaki   Okamoto Isamu   Ueda Shinya   Tsuya Asuka   Boku Narikazu   Nishio Kazuto   Fukuoka Masahiro   Yamamoto Nobuyuki   Nakagawa Kazuhiko  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1063-1071

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 study of pazopanib alone or combined with lapatinib in Japanese patients with solid tumors

By Inada-Inoue Megumi   Ando Yuichi   Kawada Kenji   Mitsuma Ayako   Sawaki Masataka   Yokoyama Taro   Sunakawa Yu   Ishida Hiroo   Araki Kazuhiro   Yamashita Keishi   Mizuno Keiko   Nagashima Fumio   Takekura Akiko   Nagamatsu Kazuo   Sasaki Yasutsuna  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 673-683

Springer Publishing Company

Access to resources Recommend Favorite